Olema Pharmaceuticals, Inc.
OLMA
$5.59
-$0.17-2.95%
NASDAQ
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | -6.75% | -4.92% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 8.58% | -5.15% | |||
Operating Income | -8.58% | 5.15% | |||
Income Before Tax | -44.08% | 9.47% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -44.08% | 9.47% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -44.08% | 9.47% | |||
EBIT | -8.58% | 5.15% | |||
EBITDA | -8.60% | 5.20% | |||
EPS Basic | -43.97% | 30.28% | |||
Normalized Basic EPS | -11.11% | 30.29% | |||
EPS Diluted | -43.97% | 30.28% | |||
Normalized Diluted EPS | -11.11% | 30.29% | |||
Average Basic Shares Outstanding | 0.08% | 29.84% | |||
Average Diluted Shares Outstanding | 0.08% | 29.84% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |